These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7603014)

  • 61. Evaluation of the wap-ras transgenic mouse as a model system for testing anticancer drugs.
    Nielsen LL; Gurnani M; Tyler RD
    Cancer Res; 1992 Jul; 52(13):3733-8. PubMed ID: 1617645
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of a nude mouse model of ras-mediated neoplasia using WR21 cells from a transgenic mouse salivary tumor.
    Nielsen LL; Gurnani M; Porter G; Trexler S; Emerson D; Tyler RD
    In Vivo; 1994; 8(3):295-302. PubMed ID: 7803707
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic background.
    Nielsen LL; Gurnani M; Catino JJ; Tyler RD
    Anticancer Res; 1995; 15(2):385-92. PubMed ID: 7763010
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
    Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S
    Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor.
    Omer CA; Chen Z; Diehl RE; Conner MW; Chen HY; Trumbauer ME; Gopal-Truter S; Seeburger G; Bhimnathwala H; Abrams MT; Davide JP; Ellis MS; Gibbs JB; Greenberg I; Koblan KS; Kral AM; Liu D; Lobell RB; Miller PJ; Mosser SD; O'Neill TJ; Rands E; Schaber MD; Senderak ET; Oliff A; Kohl NE
    Cancer Res; 2000 May; 60(10):2680-8. PubMed ID: 10825141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Strategy for developing transgenic assays for screening antineoplastic drugs that affect tubulin polymerization.
    Porter GM; Armstrong L; Nielsen LL
    Lab Anim Sci; 1995 Apr; 45(2):145-50. PubMed ID: 7603014
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Taxol: a review of its preclinical in vivo antitumor activity.
    Rose WC
    Anticancer Drugs; 1992 Aug; 3(4):311-21. PubMed ID: 1358264
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tubulin and microtubules as targets for anticancer drugs.
    Hadfield JA; Ducki S; Hirst N; McGown AT
    Prog Cell Cycle Res; 2003; 5():309-25. PubMed ID: 14593726
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.
    Wall ME; Wani MC
    Cancer Res; 1995 Feb; 55(4):753-60. PubMed ID: 7850785
    [TBL] [Abstract][Full Text] [Related]  

  • 70. What is the optimal rodent model for anti-tumor drug testing?
    Kerbel RS
    Cancer Metastasis Rev; 1998-1999; 17(3):301-4. PubMed ID: 10352884
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Orthotopic models are necessary to predict therapy of transplantable tumors in mice.
    Killion JJ; Radinsky R; Fidler IJ
    Cancer Metastasis Rev; 1998-1999; 17(3):279-84. PubMed ID: 10352881
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Trials, tribulations, and trends in tumor modeling in mice.
    Schuh JC
    Toxicol Pathol; 2004; 32 Suppl 1():53-66. PubMed ID: 15209404
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The meaning and prospect of chemosensitivity tests].
    Kojima A; Saijo N
    Rinsho Byori; 1989 Jul; (Spec No 82):98-105. PubMed ID: 2693769
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.